Archives

by in
Entry Author Date Location
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers 01/27/12 Boston
San Diego Life Sciences Roundup: Illumina, Sequenom, Acutus, & More 01/26/12 San Diego
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race 01/24/12 Boston
The Top 10 Traffic-Getting Stories at Xconomy San Diego 12/28/11 San Diego
San Diego Life Sciences Roundup: BeneChill, Sotera, Imthera, & More 12/16/11 San Diego
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers 12/16/11 Boston
Vertex Names Jeff Leiden as New CEO, Staring Down Tough Competition 12/15/11 Boston
The Hepatitis C Market: Biotech’s Version of the Daytona 500 12/12/11 National
AMAG Stock Rises, Ariad Drug Shows Improved Safety, Rhythm Adds Merck Veteran as CEO, & More Boston-Area Life Sciences News 11/11/11 Boston
Vertex Stock Drops 17% Over Two Days, As Potent Hep C Rivals Emerge 11/08/11 Boston
Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011 11/07/11 National
New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News 10/28/11 Boston
Vertex Flips Into the Black for First Time, as Hepatitis C Drug Beats Expectations Again 10/27/11 Boston
This Week’s Xconomy Report on WGBH: Security Innovation, Vertex, West Coast Acquisitions, & More 10/21/11 Boston
Third Rock Launches Sage, Glaxo Malaria Vaccine Relies on Agenus Technology, Vertex Seeks Approval of Cystic Fibrosis Drug, & More Boston-Area Life Sciences News 10/21/11 Boston
Vertex Seeks FDA Green Light for Cystic Fibrosis Drug, Second Potential Hit of Big Year 10/19/11 Boston
Anadys Pharmaceuticals Surprises the Street, Gets Acquired by Roche for $230M 10/17/11 San Diego
Boston Xconomists and Area Innovators Gather for Special Xconomy Event: The Photos 10/13/11 Boston
Cocrystal, Led by Icos Vets and Stanford Nobelist, Hunts for Next Big Thing for Hepatitis C 09/22/11 Seattle
Stirring the Pot Once in a While Doesn’t Hurt, and It Could Help Biotech Break its Malaise 09/19/11 National
Cocrystal Discovery Snags $7.5M in Hepatitis C Collaboration With Teva 09/15/11 Seattle
Dramatic Changes in Hepatitis C Treatment Expected to Continue 09/06/11 San Diego
Fearless Fantasy Football, Uh, I Mean Biotech, Predictions for the Season Ahead 09/06/11 National
The Fall of Pfizer: How Big is Too Big for Pharma Innovation? 08/29/11 National
Xconomist of the Week: Tony Coles’ Journey from Mass General Doctor to SF Biotech CEO 08/18/11 National
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus 08/08/11 National
Vertex Smashes Wall Street Sales Expectations In Hepatitis C Drug Debut 07/28/11 Boston
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent 07/18/11 National
aTyr Pharma Looks to Strike Balance Between Nonprofits, and Really Big For-Profits 07/06/11 San Diego
Brightcove Moving to Boston, Looks to Hire 07/05/11 Boston
Page 3 of 9 « previous page · next page »